Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure
Am Health Drug Benefits
.
2015 Sep;8(6):330-4.
Author
Loretta Fala
1
Affiliation
1
Medical Writer.
PMID:
26557227
PMCID:
PMC4636283
No abstract available